Literature DB >> 20202425

Paenibacillus larvae Bacteremia in injection drug users.

Siegbert Rieg1, Tilman Martin Bauer, Gabriele Peyerl-Hoffmann, Jurgen Held, Wolfgang Ritter, Dirk Wagner, Winfried Vinzenz Kern, Annerose Serr.   

Abstract

Paenibacillus larvae causes American foulbrood in honey bees. We describe P. larvae bacteremia in 5 injection drug users who had self-injected honey-prepared methadone proven to contain P. larvae spores. That such preparations may be contaminated with spores of this organism is not well known among pharmacists, physicians, and addicts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202425      PMCID: PMC3322038          DOI: 10.3201/eid1603.091457

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


As a consequence of needle sharing and repeated parenteral administration of nonsterile material, injection drug users risk becoming ill from a variety of infections, including HIV, hepatitis C, endocarditis, and skin and soft tissue infections (). Febrile episodes in injection drug users are common, yet distinguishing between febrile reactions caused by toxins or impurities in the injected substance and true infections may be difficult (,). Methadone hydrochloride, which is widely used for opioid substitution, can be mixed with viscous substances such as syrup to yield a solution that is not suitable for misuse through self-injection. Methadone syrup is intended to be taken only as an oral medication. Some pharmacies use honey instead of syrup to prepare such a solution. Paenibacillus larvae is a spore-forming gram-positive microorganism known for its ability to cause American foulbrood, a severe and notifiable disease of honey bees (Apis mellifera) () (Figure). P. larvae is endemic to bee colonies worldwide. The organism can be cultured from <10% of honey samples from Germany but from >90% of samples from honeys imported from other countries (). P. larvae spores are highly resilient and can survive in honey for years (,). We describe P. larvae bacteremia in 5 patients who had a history of intravenous drug abuse and were in a program of opioid substitution that used methadone.
Figure

Paenibacillus larvae gram-positive, spore-forming, rod-shaped bacteria (A) (Gram stain, original magnification ×1,000) with the ability to form giant whips upon sporulation (B) (nigrosine stain, original magnification ×1,000). In American foulbrood (AFB), newly hatched honey bee larvae become infected through ingestion of brood honey containing P. larvae spores. After germination and multiplication, infected bee larvae die within a few days and are decomposed to a ropy mass, which releases millions of infective spores after desiccation. C) AFB-diseased larvae are beige or brown in color and have diminished segmentation (healthy and AFB-diseased larvae). D) Clinical diagnosis of AFB can be made by a matchstick test, demonstrating the viscous, glue-like larval remains adhering to the cell wall.

Paenibacillus larvae gram-positive, spore-forming, rod-shaped bacteria (A) (Gram stain, original magnification ×1,000) with the ability to form giant whips upon sporulation (B) (nigrosine stain, original magnification ×1,000). In American foulbrood (AFB), newly hatched honey bee larvae become infected through ingestion of brood honey containing P. larvae spores. After germination and multiplication, infected bee larvae die within a few days and are decomposed to a ropy mass, which releases millions of infective spores after desiccation. C) AFB-diseased larvae are beige or brown in color and have diminished segmentation (healthy and AFB-diseased larvae). D) Clinical diagnosis of AFB can be made by a matchstick test, demonstrating the viscous, glue-like larval remains adhering to the cell wall.

The Study

All patients sought treatment for fever ranging from 37.8°C to 39.8°C and admitted to continuing to inject illicit drugs or methadone. Information about patient characteristics, clinical signs and symptoms, laboratory and micobiologic investigations, and treatment details are summarized in the Table. P. larvae was identified in blood cultures (BacT/ALERT 3D-System; bioMérieux, Marcy l’Etoile, France) of each patient described. The clinical course of P. larvae bacteremia was benign in 3 patients, and complications developed in 2 patients. Patient 1 had relapsing disease and spontaneous bacterial peritonitis; patient 4 had pulmonary embolism without definite evidence of septic embolism. Patients 2 and 3 recovered without specific antimicrobial drug treatment; for patients 4 and 5, defervescence and negative follow-up blood cultures were observed after they received treatment with β-lactam agents (imipenem or cefuroxime). The recurrent P. larvae infection observed in patient 1 was probably the consequence of repeated injection of contaminated methadone rather than an inadequate response to antimicrobial drug therapy.
Table

Patient characteristics, clinical presentation, treatment, and laboratory and microbiologic results of 5 patients with Paenibacillus larvae bacteremia*

CharacteristicPatient no.
12345
Age, y/sex28/F32/M20/M35/M27/F
Date evaluated2003 Jul2003 Sep2003 Oct2004 Feb2008 May
Clinical samples with identification of P. larvaeCulture of ascites (2003 Jul), blood culture (2003 Aug)Blood cultureBlood cultureBlood cultureBlood culture
CRP, mg/L4317113740
Leukocyte count, × 109/L23.013.09.311.819.2
Medical historyIVDA, hepatitis C, Child B liver cirrhosis with refractory ascitesIVDA, hepatitis C, hepatitis BIVDA, hepatitis CIVDA, hepatitis C, history of hepatitis AIVDA, hepatitis C, alcohol abuse
Clinical signs and symptomsDecompensated liver cirrhosis, ascites, fever (39.2°C)Persistent weakness and malaise, fever (39.2°C)Somnolence, fever (38.2°C)Tachypnoe, right-sided pleuritic chest pain, fever (37.8°C)Severe anemia, spontaneous mucosal bleeding, fever (39.8°C)
Clinical conditions other than bacteremiaBacterial peritonitis, hepatic encephalopathy after TIPS placementAcute hepatitis B diagnosed 1 mo before bacteremia, eosinophiliaMethadone/ diazepam overdosePulmonary embolism, infarction pneumonia, deep vein thrombosisSubsequently diagnosed with ITP, Paracoccus yeei and Micrococcus luteus bacteremia
Treatment (duration)Meropenem (7 d) followed by ampicillin IV (2 d), then meropenem (7 d) followed by penicillin G (14 d)NoneNoneCefuroxim IV (7 d)Imipenem (21 d)

*CRP, C-reactive protein (reference range <5 mg/L); IVDA, intravenous drug abuse; TIPS, transjugular intrahepatic portosystemic shunt; ITP, idiopathic thrombocytopenic purpura; IV, intravenous.
†P. larvae identified after culture using 16S rRNA gene sequencing.

*CRP, C-reactive protein (reference range <5 mg/L); IVDA, intravenous drug abuse; TIPS, transjugular intrahepatic portosystemic shunt; ITP, idiopathic thrombocytopenic purpura; IV, intravenous.
†P. larvae identified after culture using 16S rRNA gene sequencing. In 2 cases, culture of the honey used to prepare methadone or of honey-containing ready-to-use methadone also yielded P. larvae. Honey and methadone samples were diluted in sterile phosphate-buffered saline and cultured with or without heat pretreatment (90°C, 10 min) under aerobic and anaerobic conditions at 37°C for 3–4 days by using Columbia blood agar and MYPGD (Mueller-Hinton broth, yeast extract, potassium phosphate, glucose, pyruvate) agar. Colonies from positive blood or honey or methadone cultures with an appropriate macroscopic appearance and gram-stain morphology as well as negative catalase reaction were further identified by PCR amplification and 16S rRNA gene sequencing according to published protocols (). Obtained sequences were analyzed by using the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

Conclusions

We detected P. larvae in sterile compartments of 5 patients with clinical and laboratory evidence of infection. Given the fact that all patients were injection drug users, the mode of infection was thought to be intravenous administration of contaminated methadone, resulting in P. larvae bacteremia. Our hypothesis is supported by the isolation of P. larvae from honey or honey-containing methadone provided to 2 patients. Recently, several Paenibacillus species have been reported to cause bacteremic infections in humans. Among these are P. thiaminolyticus (bacteremia in a patient undergoing hemodialysis) (), P. konsidensis (bacteremia in a febrile patient with hematemesis) (), P. alvei (prosthetic joint infection with bacteremia) (), and P. polymyxa (bacteremia in a patient with cerebral infarction) (). Furthermore, the novel species P. massiliensis, P. sanguinis, and P. timonensis were isolated from blood cultures of patients with carcinoma, interstitial nephropathy, and leukemia, respectively (). Pseudobacteremia of P. hongkongensis and P. macerans has been reported (,). Several aspects provide strong evidence for a genuine P. larvae bacteremia in the cases described here. First, the present cases were observed over a period of several years, and detection of P. larvae thus occurred in different charges of blood culture bottles, which argues against pseudobacteremia. Second, isolation of P. larvae was reported independently by 2 microbiology laboratories, making contamination highly unlikely. Third, in patient 1 isolation succeeded at different times and in samples of different compartments. Moreover, the detection of P. larvae in honey-prepared methadone and honey strongly suggests genuine bacteremia as a consequence of injection of contaminated material. Biochemical and molecular identification of P. larvae may be difficult and time-consuming. Misinterpretation of blood culture results because of incomplete differentiation or confusion with other gram-positive spore forming-bacteria (e.g., Bacillus species) has to be taken into consideration. Underestimation of the frequency of true P. larvae bacteremia therefore cannot be excluded. Thus, infectious disease physicians, microbiologists, and pharmacists need to be aware that injection of material contaminated with P. larvae, such as honey-prepared methadone, may cause bacteremic infection.
  11 in total

Review 1.  Management of the hospitalized injection drug user.

Authors:  John A Hopper; Tariq Shafi
Journal:  Infect Dis Clin North Am       Date:  2002-09       Impact factor: 5.982

2.  [A case of Paenibacillus polymyxa bacteremia in a patient with cerebral infarction].

Authors:  Yoshiyuki Nasu; Yoshitomo Nosaka; Yoshihito Otsuka; Toshihiko Tsuruga; Michiko Nakajima; Yasuhiro Watanabe; Masahiko Jin
Journal:  Kansenshogaku Zasshi       Date:  2003-10

3.  Comparison of different DNA fingerprinting techniques for molecular typing of Bartonella henselae isolates.

Authors:  A Sander; M Ruess; S Bereswill; M Schuppler; B Steinbrueckner
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 4.  Diagnosis of American foulbrood in honey bees: a synthesis and proposed analytical protocols.

Authors:  D C de Graaf; A M Alippi; M Brown; J D Evans; M Feldlaufer; A Gregorc; M Hornitzky; S F Pernal; D M T Schuch; D Titera; V Tomkies; W Ritter
Journal:  Lett Appl Microbiol       Date:  2006-12       Impact factor: 2.858

5.  Paenibacillus macerans pseudobacteremia resulting from contaminated blood culture bottles in a neonatal intensive care unit.

Authors:  G A Noskin; T Suriano; S Collins; S Sesler; L R Peterson
Journal:  Am J Infect Control       Date:  2001-04       Impact factor: 2.918

6.  Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis.

Authors:  Jie Ouyang; Zhiheng Pei; Larry Lutwick; Sharvari Dalal; Liying Yang; Nicholas Cassai; Kuldip Sandhu; Bruce Hanna; Rosemary L Wieczorek; Martin Bluth; Matthew R Pincus
Journal:  Ann Clin Lab Sci       Date:  2008       Impact factor: 1.256

7.  Paenibacillus konsidensis sp. nov., isolated from a patient.

Authors:  Kwan Soo Ko; Yeon-Sook Kim; Mi Young Lee; So Young Shin; Dong Sik Jung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Int J Syst Evol Microbiol       Date:  2008-09       Impact factor: 2.747

8.  Paenibacillus massiliensis sp. nov., Paenibacillus sanguinis sp. nov. and Paenibacillus timonensis sp. nov., isolated from blood cultures.

Authors:  Véronique Roux; Didier Raoult
Journal:  Int J Syst Evol Microbiol       Date:  2004-07       Impact factor: 2.747

9.  Pseudobacteraemia in a patient with neutropenic fever caused by a novel paenibacillus species: Paenibacillus hongkongensis sp. nov.

Authors:  J L L Teng; P C Y Woo; K W Leung; S K P Lau; M K M Wong; K Y Yuen
Journal:  Mol Pathol       Date:  2003-02

10.  Skin and soft tissue infections and vascular disease among drug users, England.

Authors:  Charles Irish; Roy Maxwell; Mark Dancox; Paul Brown; Caroline Trotter; Julia Verne; Mary Shaw
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more
  12 in total

1.  Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus.

Authors:  Janina Ferrand; Tahar Hadou; Christine Selton-Suty; François Goehringer; Nicolas Sadoul; Corentine Alauzet; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

2.  Pathogenicity of Bacteria Contaminating Blood Products.

Authors:  Sören G Gatermann
Journal:  Transfus Med Hemother       Date:  2011-07-12       Impact factor: 3.747

3.  C3larvin toxin, an ADP-ribosyltransferase from Paenibacillus larvae.

Authors:  Daniel Krska; Ravikiran Ravulapalli; Robert J Fieldhouse; Miguel R Lugo; A Rod Merrill
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

4.  Low-molecular-weight metabolites secreted by Paenibacillus larvae as potential virulence factors of American foulbrood.

Authors:  Hedwig-Annabell Schild; Sebastian W Fuchs; Helge B Bode; Bernd Grünewald
Journal:  Appl Environ Microbiol       Date:  2014-02-07       Impact factor: 4.792

5.  Non-contiguous-Finished Genome Sequence and Description of Paenibacillus camerounensis sp. nov.

Authors:  Mamadou Bhoye Keita; Roshan Padhmanabhan; Catherine Robert; Eric Delaporte; Didier Raoult; Pierre-Edouard Fournier; Fadi Bittar
Journal:  Microb Ecol       Date:  2015-12-29       Impact factor: 4.552

Review 6.  Phagocytosis and oxycytosis: two arms of human innate immunity.

Authors:  Hayk Minasyan
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 7.  Biofertilizer microorganisms accompanying pathogenic attributes: a potential threat.

Authors:  Mohsin Tariq; Farwah Jameel; Usman Ijaz; Muhammad Abdullah; Kamran Rashid
Journal:  Physiol Mol Biol Plants       Date:  2022-02-08

8.  A Case of Paenibacillus pasadenensis Bacteremia in a Patient with Acute Respiratory Distress Syndrome after Microsurgical Clipping.

Authors:  Hee Jung Yoon; Hyung Woo Yim; Kwan Soo Ko
Journal:  Infect Chemother       Date:  2015-03-30

9.  Non-contiguous finished genome sequence and description of Paenibacillus gorillae sp. nov.

Authors:  Mamadou Bhoye Keita; Roshan Padhmananabhan; Aurélia Caputo; Catherine Robert; Eric Delaporte; Didier Raoult; Pierre-Edouard Fournier; Fadi Bittar
Journal:  Stand Genomic Sci       Date:  2014-03-15

10.  Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates.

Authors:  Francesco Celandroni; Sara Salvetti; Sokhna Aissatou Gueye; Diletta Mazzantini; Antonella Lupetti; Sonia Senesi; Emilia Ghelardi
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.